Mesenchymal Stem Cells (MSCs) and Secretome therapy for Sepsis
Tahapan Penelitian : Recruit
Sponsor:
PT. Prodia StemCell Indonesia
Mitra Pelaksana:
Gatot Soebroto Army Hospital
No Registry
INA-3KMOPHC6
Tanggal Input Registry : 03-02-2025
| Tracking Information | |
|---|---|
| Tanggal Antisipasi Studi | 27-11-2024 |
| Outcome Primer | Improved sepsis condition and kidney function, with differences in inflammatory markers and hospital stay duration after therapy with MSCs and secretome. |
| Outcome Skunder | |
| Descriptive Information | |
| Judul Penelitian Popular | Mesenchymal Stem Cells (MSCs) and Secretome therapy for Sepsis |
| Judul Penelitian Ilmiah | Mesenchymal Stem Cells (MSCs) and Secretome therapy for Sepsis |
| Jenis Penelitian | Interventional |
| Intervensi | - Control group: SOC - Intervention 1: SOC+Mesenchymal Stem Cells - Intervention 2: SOC+Mesenchymal Stem Cells+Secretome |
| Jumlah Subyek Penelitian | 15 |
| Recruitment Information | |
| Eligibility Criteria | Inclusion Criteria: - Patients aged 18-80 years - Has two qSOFA criteria - Patients with sepsis and clinically caused by infectionExclusion Criteria: Patient is allergic to one of the components of UC-MSC or its Secretome, not undergoing hormone treatment or other insulin resistance treatments, refuses or does not comply with some/all of the study process, diagnosed positive for hepatitis A, B, C, and HI |
| Administrative Information | |
| Nomor Persetujuan Etik | 51/1/KEPK/2024 |
| Nomor Persetujuan Material Transfer Agreement | Not applicable |
| Nomor Persetujuan Pelaksanaan Uji Klinik | Not applicable |
| Other Study ID Numbers | |
| Contact Person | Rima Haifa, S.Si, M. Farm-Klin |